These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 18496518

  • 1. Glucocorticoid receptor antagonism augments fluoxetine-induced downregulation of the 5-HT transporter.
    Johnson DA, Ingram CD, Grant EJ, Craighead M, Gartside SE.
    Neuropsychopharmacology; 2009 Jan; 34(2):399-409. PubMed ID: 18496518
    [Abstract] [Full Text] [Related]

  • 2. Glucocorticoid receptor antagonists hasten and augment neurochemical responses to a selective serotonin reuptake inhibitor antidepressant.
    Johnson DA, Grant EJ, Ingram CD, Gartside SE.
    Biol Psychiatry; 2007 Dec 01; 62(11):1228-35. PubMed ID: 17651703
    [Abstract] [Full Text] [Related]

  • 3. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
    van Amsterdam C, Seyfried CA.
    Psychopharmacology (Berl); 2014 Jun 01; 231(12):2547-58. PubMed ID: 24419272
    [Abstract] [Full Text] [Related]

  • 4. Chronic treatment with fluoxetine decreases cerebral metabolic responses to the 5-HT1A agonist 8-hydroxy-2(di-N-propylamino)tetralin and increases those to the 5-HT2A/2C agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane and to the dopaminergic agonist apomorphine.
    Freo U, Merico A, Ermani M, Ori C.
    Brain Res; 2010 Jun 04; 1335():24-34. PubMed ID: 20381465
    [Abstract] [Full Text] [Related]

  • 5. Differential involvement of 5-HT(1A) and 5-HT(1B/1D) receptors in human interferon-alpha-induced immobility in the mouse forced swimming test.
    Zhang H, Wang W, Jiang Z, Shang J, Zhang L.
    Arzneimittelforschung; 2010 Jun 04; 60(3):109-15. PubMed ID: 20422941
    [Abstract] [Full Text] [Related]

  • 6. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist.
    Page ME, Cryan JF, Sullivan A, Dalvi A, Saucy B, Manning DR, Lucki I.
    J Pharmacol Exp Ther; 2002 Sep 04; 302(3):1220-7. PubMed ID: 12183683
    [Abstract] [Full Text] [Related]

  • 7. Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex.
    Dawson LA, Nguyen HQ, Smith DL, Schechter LE.
    J Psychopharmacol; 2002 Jun 04; 16(2):145-52. PubMed ID: 12095073
    [Abstract] [Full Text] [Related]

  • 8. Role of 5-HT(1A) receptors in fluoxetine-induced lordosis inhibition.
    Guptarak J, Sarkar J, Hiegel C, Uphouse L.
    Horm Behav; 2010 Jul 04; 58(2):290-6. PubMed ID: 20223238
    [Abstract] [Full Text] [Related]

  • 9. Effects of chronic fluoxetine treatment in the presence and absence of (+/-)pindolol: a microdialysis study.
    Dawson LA, Nguyen HQ, Smith DI, Schechter LE.
    Br J Pharmacol; 2000 Jun 04; 130(4):797-804. PubMed ID: 10864885
    [Abstract] [Full Text] [Related]

  • 10. Chronic fluoxetine induces opposite changes in G protein coupling at pre and postsynaptic 5-HT1A receptors in rat brain.
    Castro M, Diaz A, del Olmo E, Pazos A.
    Neuropharmacology; 2003 Jan 04; 44(1):93-101. PubMed ID: 12559126
    [Abstract] [Full Text] [Related]

  • 11. WAY100635 prevents the changes induced by fluoxetine upon the 5-HT1A receptor functionality.
    Castro E, Díaz A, Rodriguez-Gaztelumendi A, Del Olmo E, Pazos A.
    Neuropharmacology; 2008 Dec 04; 55(8):1391-6. PubMed ID: 18809415
    [Abstract] [Full Text] [Related]

  • 12. Receptor-genes cross-talk: effect of chronic 5-HT(1A) agonist 8-hydroxy-2-(di-n-propylamino) tetralin treatment on the expression of key genes in brain serotonin system and on behavior.
    Popova NK, Naumenko VS, Cybko AS, Bazovkina DV.
    Neuroscience; 2010 Aug 11; 169(1):229-35. PubMed ID: 20423722
    [Abstract] [Full Text] [Related]

  • 13. Deep brain stimulation and fluoxetine exert different long-term changes in the serotonergic system.
    Volle J, Bregman T, Scott B, Diwan M, Raymond R, Fletcher PJ, Nobrega JN, Hamani C.
    Neuropharmacology; 2018 Jun 11; 135():63-72. PubMed ID: 29505786
    [Abstract] [Full Text] [Related]

  • 14. 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat.
    De Vry J, Schreiber R, Melon C, Dalmus M, Jentzsch KR.
    Eur Neuropsychopharmacol; 2004 Dec 11; 14(6):487-95. PubMed ID: 15589388
    [Abstract] [Full Text] [Related]

  • 15. Effects of the antidepressant fluoxetine on the subcellular localization of 5-HT1A receptors and SERT.
    Descarries L, Riad M.
    Philos Trans R Soc Lond B Biol Sci; 2012 Sep 05; 367(1601):2416-25. PubMed ID: 22826342
    [Abstract] [Full Text] [Related]

  • 16. Acute and chronic effects of citalopram on 5-HT1A receptor-labeling by [18F]MPPF and -coupling to receptors-G proteins.
    Moulin-Sallanon M, Charnay Y, Ginovart N, Perret P, Lanfumey L, Hamon M, Hen R, Fagret D, Ibáñez V, Millet P.
    Synapse; 2009 Feb 05; 63(2):106-16. PubMed ID: 19016488
    [Abstract] [Full Text] [Related]

  • 17. The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram.
    Arborelius L, Nomikos GG, Hertel P, Salmi P, Grillner P, Höök BB, Hacksell U, Svensson TH.
    Naunyn Schmiedebergs Arch Pharmacol; 1996 May 05; 353(6):630-40. PubMed ID: 8738296
    [Abstract] [Full Text] [Related]

  • 18. Insensitivity of NMRI mice to selective serotonin reuptake inhibitors in the tail suspension test can be reversed by co-treatment with 5-hydroxytryptophan.
    Jacobsen JP, Nielsen EØ, Hummel R, Redrobe JP, Mirza N, Weikop P.
    Psychopharmacology (Berl); 2008 Aug 05; 199(2):137-50. PubMed ID: 18496675
    [Abstract] [Full Text] [Related]

  • 19. A chronic treatment with fluoxetine decreases 5-HT(1A) receptors labeling in mice selected as a genetic model of helplessness.
    Naudon L, El Yacoubi M, Vaugeois JM, Leroux-Nicollet I, Costentin J.
    Brain Res; 2002 May 17; 936(1-2):68-75. PubMed ID: 11988231
    [Abstract] [Full Text] [Related]

  • 20. Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter.
    Fabre V, Beaufour C, Evrard A, Rioux A, Hanoun N, Lesch KP, Murphy DL, Lanfumey L, Hamon M, Martres MP.
    Eur J Neurosci; 2000 Jul 17; 12(7):2299-310. PubMed ID: 10947809
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.